Arbutus Biopharma
ABUS
#6153
Rank
NZ$1.47 B
Marketcap
NZ$7.66
Share price
-4.15%
Change (1 day)
26.84%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): NZ-$0.44

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is NZ-$0.44. In 2024 the company made an earnings per share (EPS) of NZ-$0.65 an increase over its 2023 EPS that were of NZ-$0.75.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.44-31.98%
2024NZ-$0.65-13.64%
2023NZ-$0.75-4.35%
2022NZ-$0.78-44.58%
2021NZ-$1.41-17%
2020NZ-$1.70-65.4%
2019NZ-$4.91138.84%
2018NZ-$2.06-22.44%
2017NZ-$2.65-78.45%
2016NZ-$12.31424.64%
2015NZ-$2.35-20.19%
2014NZ-$2.9487.96%
2013NZ-$1.56-142.59%
2012NZ$3.67-342.7%
2011NZ-$1.51-25.82%
2010NZ-$2.0447.8%
2009NZ-$1.38-43.55%
2008NZ-$2.44158.91%
2007NZ-$0.94-111.88%
2006NZ$7.95-552.53%
2005NZ-$1.76-71.77%
2004NZ-$6.22-14.48%
2003NZ-$7.28-8.95%
2002NZ-$7.9970.07%
2001NZ-$4.7048.01%
2000NZ-$3.17-38.54%
1999NZ-$5.17-24.6%
1998NZ-$6.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.10-76.92% Bahamas
NRC Health
NRC
NZ$1.19-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA